AMIX MEXC RealStocks
Own real AMIX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-16 10:35:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Autonomix Medical, Inc. (AMIX) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $1.33, with a market capitalization of $2.80M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.31 to $32.55. This page covers its latest market performance, valuation, price trends and company information.
$2.80M | |
$1.36 | |
$1.44 | |
$1.33 | |
$1.37 | |
7.88K | |
2.04M | |
-- | |
$32.55 | |
$1.31 | |
-- | |
-- |
Autonomix Medical, Inc. (AMIX) is trading at $1.33 in pre-market trading as of 2026-11-16 10:33:00, down 2.92% ($0.04) from the previous close of $1.37
Pre-market trading shows how investors are pricing AMIX before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, Autonomix Medical, Inc. (AMIX) moved from $1.52 to $1.33, representing a decline of 12.50% ($0.19).
The stock traded between $1.31 and $3.30 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 10.67 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.1%
AMIX is currently trading at $1.33, placing it 0.1% of the way from its 52-week low of $1.31 to its 52-week high of $32.55. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 11 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Autonomix Medical, Inc. (AMIX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to AMIX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between AMIX shares and USD.
AMIX Shares to USD
1.00 AMIX shares = 1.33 USD
Calculations are estimates based on the latest available price and are for reference only.